Cardiol Therapeut…
CACADCardiol Therapeutics Inc Class A (TO:CRDL) — Biotechnology: Biological Products (No Diagnostic Substances). Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site Web
- cardiolrx.com
- Relations avec les Investisseurs
- cardiolrx.com/investors/events-presentations/
- Secteur
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Siège Social
- OAKVILLE, Canada
- Direction
- David G. Elsley
- Employés
- 18
- Actions en Circulation
- 121.51 M au 2025-12-31
- Flottant
- 91.98 M
- Capitalisation Boursière
- 149.46 M USD
- Initiés
- 2.27%
- Investisseurs Institutionnels
- 26.4%
- Secteur d'Activité (SIC)
- Biological Products, (No Diagnostic Substances)
- P/E
- perte
- P/B
- 7.83
- FCF
- −23.9 M CAD
- Dette
- ?
- Résultats et FCF — pour les 12 mois à 31.12.2025 (dernier rapport de l'entreprise).
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Principaux Actionnaires
| Détenteur | Participation | Actions | Date du Rapport |
|---|---|---|---|
| MMCAP International, Inc… | 13.12% | 15.6 M | 2026-06-30 |
| Tejara Capital Ltd | 4.3% | 5.11 M | 2026-06-30 |
| Ikarian Capital, LLC | 2.8% | 3.33 M | 2026-06-30 |
| Elsley (David) (Director… | ≈1.13% | 1.34 M | 2025-10-17 |
| Boothbay Fund Management… | 0.82% | 975 721 | 2026-06-30 |
| Citadel Advisors Llc | 0.67% | 796 529 | 2026-06-30 |
| Renaissance Technologies… | 0.65% | 772 837 | 2026-06-30 |
| Two Sigma Investments, L… | 0.63% | 746 937 | 2026-06-30 |
| Hamer (Andrew Warwick M.… | ≈0.62% | 739 947 | 2026-08-28 |
| Integrity Alliance, Llc. | 0.33% | 388 492 | 2026-06-30 |
| Morgan Stanley | 0.3% | 355 030 | 2026-06-30 |
| Torreamione (Guilermo) (… | ≈0.28% | 334 309 | 2026-09-08 |
| Goldman Sachs Group Inc | 0.28% | 333 900 | 2026-06-30 |
| Chao (Jennifer M) (Direc… | ≈0.12% | 146 667 | 2026-08-21 |
| Loxam (Teri) (Director o… | ≈0.12% | 146 667 | 2026-08-21 |
| Fidelity Concord Street… | 0.05% | 60 663 | 2026-07-31 |
